Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas)
Status:
Terminated
Trial end date:
2020-08-30
Target enrollment:
Participant gender:
Summary
To tested if the adding of consolidative SBRT to TKI in EGFR mutated patients with less than
or equal to 5 metastatic sites (primary + 5) will improve progression free survival (PFS)
compared to TKI alone.